Bioharvest Sciences (BHST) EBT (2023 - 2025)

Bioharvest Sciences' EBT history runs 3 years deep, the most recent figure standing at -$2.3 million for Q4 2025.

• On a quarterly basis, EBT rose 23.07% year-over-year to -$2.3 million in Q4 2025; TTM through Dec 2025 was -$11.1 million, a 14.3% increase from a year earlier, with the FY2025 full-year figure at -$11.1 million, up 14.3% from the prior year.
• EBT improved to -$2.3 million in Q4 2025 per BHST's latest filing, from -$2.4 million in the prior quarter.
• Across five years, EBT topped out at $2.8 million in Q2 2023 and bottomed at -$17.9 million in Q4 2023.
• The 3-year median for EBT is -$2.4 million (2025), against an average of -$3.4 million.
• Across the five-year window, EBT jumped 83.52% in 2024 and slumped 488.21% in 2025, its largest moves.
• Year by year, EBT stood at -$17.9 million in 2023, then jumped by 83.52% to -$2.9 million in 2024, then advanced by 23.07% to -$2.3 million in 2025.
• Per Business Quant, the three latest BHST EBT figures stand at -$2.3 million (Q4 2025), -$2.4 million (Q3 2025), and -$4.0 million (Q2 2025).